Skip to main content
. 2002 Nov;54(5):528–534. doi: 10.1046/j.1365-2125.2002.01690.x
Drug classes Examples Coefficient of variation
1 C04A Peripheral vasodilators (cinnarizine, nimodipine, etc.) 196.99
2 N06D Anti-dementia drugs (piracetam, levocarnitine, etc.) 179.56
3 C10A B Fibrates (gemfibrozil, clofibrate, etc.) 156.26
4 H05B A Calcitonin preparations 135.71
5 N05C Hypnotics and sedatives (temazepam, phenobarbitone, etc.) 121.21
6 R05C Expectorants (acetylcysteine, guaifenesin, etc.) 92.05
7 H01A C Growth hormone (somatropin) 91.41
8 R03D A Xanthines (theophylline, aminophylline, etc.) 85.01
9 A02B C Proton pump inhibitors (omeprazole, lansoprazole, etc.) 82.10
10 R03B A Glucocorticoids, inhalants (beclomethasone, budesonide, etc.) 78.80
11 C10A A HMG CoA reductase inhibitors (simvastatin, pravastatin, etc.) 73.53
12 N03A Antiepileptics (phenytoin, carbamazepine, etc.) 72.55
13 S01E Antiglaucoma preparations and miotics (pilocarpine, timolol, etc.) 71.24
14 M05B Drugs affecting mineralization (alendronate, etidronate, etc.) 68.59
15 R03A Adrenergics, inhalants (salbutamol, salmeterol, etc.) 63.16
16 N04 Anti-Parkinson drugs (levodopa, bromocriptine, etc.) 58.21
17 A07E Intestinal anti-inflammatory agents (sulfasalazine, mesalazine, etc.) 56.43
18 A10A Insulins and analogues 55.40
19 H03B Antithyroid preparations (thiamazole, propylthiouracil, etc.) 48.83